The subject of this publication is the conclusion of non-exclusive agreements on various contrast agent active ingredients / active ingredient combinations within the framework of an open-house procedure, which are prescribed and issued in the SSB at the expense of the health insurance companies in Rhineland-Palatinate and Saarland. More details on the active substances concerned can be found in the division into specialist groups (Appendix 5 to this publication). Contrast media of each future contractual partner can be ordered for a specialty group during the contract period due to the economic efficiency requirement by the contract physicians, who are informed about these economic sources of supply; they are considered economical. Contract physicians are obliged to meet their need for contrast media from a specialist group with the products of the contractual partner or one of the contractual partners. For each specialist group there is a fixed, non-negotiable contract price for the duration of the contract.
Section EDescription: Non-ionic iodine-containing monomeric, low-osmolar, water-soluble nephrotropic X-ray contrast media
Application: intrathecal. More possible.
Application areas:
- cervical, thoracic and lumbar myelography and radioculography
- CT myelography
Active ingredients / combinations (ATC): Iohexol (V08AB02) and / or Iopamidol (V08AB04) and / or Iopromide (V08AB05) and / or Iomeprol (V08AB10) and / or Iobitridol (V08AB11) and / or Ioversol (V08AB07) and / or more possible.
Dosage forms: all approved dosage forms of an active ingredient must be offered.
Concentration: 200 mg/ml - 300 mg/ml, all concentrations of an active substance must be offered.
Pack size: all approved pack sizes of an active substance must be offered.
Further information can be found in Appendix 5 to the request for quotation.
Section RName: ultrasound contrast medium
Application: Intravenous use
Areas of application: echocardiography, others possible
Active ingredients / combinations (ATC): Albumin microspheres, containing perflutren (V08DA01)
Dosage form: all dosage forms of the active ingredient
Concentration: all concentrations possible
Pack size: all pack sizes of the active ingredient
Further information can be found in Appendix 5 to the request for quotation.
Section SName: ultrasound contrast medium
Application: Intravenous use
Areas of application: echocardiography, Doppler sonography (macro and microvasculature), ultrasound of the lower urinary tract
Active ingredients / combinations (ATC): Sulfur hexafluoride (V08DA05)
Dosage form: all dosage forms of the active ingredient
Concentration: all concentrations possible
Pack size: All pack sizes of the active ingredient.
Further information can be found in Appendix 5 to the request for quotation.
Section TName: Superparamagnetic MRI contrast agent (iron oxide)
Application: Intravenous use
Indications: MRI of the liver
Active substances/combinations (ATC): Ferucarbotran (V08CB03)
Dosage form: all dosage forms of the active ingredient
Concentration: all concentrations possible
Pack size: All pack sizes of the active ingredient.
Further information can be found in Appendix 5 to the request for quotation.
Section GName Non-ionic iodine-containing monomeric, low-osmolar, water-soluble nephrotropic X-ray contrast media
Application: intra-arterial and intravenous and intracavity. More possible.
Application areas:
- urography,
- phlebography,
- CT contrast enhancement
- digital subtraction angiography (DSA)
Active ingredients / combinations (ATC): Iohexol (V08AB02) and / or Iopamidol (V08AB04) and / or Iopromide (V08AB05) and / or Iomeprol (V08AB10) and / or Iobitridol (V08AB11) and / or Ioversol (V08AB07) and / or more possible.
Dosage forms: all approved dosage forms of an active ingredient must be offered.
Concentration: 150 mg/ml - 250 mg/ml, all concentrations of an active substance must be offered.
Pack size: all approved pack sizes of an active substance must be offered.
Further information can be found in Appendix 5 to the request for quotation.
Section HDescription: Non-ionic iodine-containing dimeric, low-osmolar, water-soluble nephrotropic X-ray contrast media.
Application: intra-arterial and intravenous. More possible.
Application areas:
- cerebral angiography, abdominal angiography, peripheral arteriography, venography,
- urography,
- Contrast enhancement in computed tomography (CT).
Active ingredients / combinations (ATC): Iodixanol (V08AB09) and / or others possible.
Dosage forms: all approved dosage forms of an active ingredient must be offered.
Concentrations must be offered cumulatively:
1. 270 mg/ml (all concentrations of an active substance must be offered)
2. 320 mg/ml (all concentrations of an active substance must be offered)
(at least all areas of application must be covered together).
Pack size: all approved pack sizes of an active substance must be offered.
Further information can be found in Appendix 5 to the request for quotation.
Section JName: Paramagnetic extracellular linear contrast media for MRI.
Application: Intra-articular application.
Areas of application: Direct magnetic resonance arthrography.
NSF risk: high NSF risk class.
Active ingredients / combinations (ATC): gadopentetic acid (V08CA01).
Dosage forms: All dosage forms of the active ingredient for this indication.
Concentration: 0.002 mmol / ml.
Pack size: All pack sizes of the active ingredient for this indication.
Further information can be found in Appendix 5 to the request for quotation.
Section MName: Paramagnetic extracellular macrocyclic contrast media for MRI.
Application: Intra-articular application.
Areas of application: Direct magnetic resonance arthrography.
NSF risk: Low NSF risk class.
Active ingredients / combinations (ATC): Gadoteric acid (V08CA02).
Dosage forms: All dosage forms of the active ingredient for this indication.
Concentration: 0.0025 mmol / ml.
Pack size: All pack sizes of the active ingredient for this indication.
Further information can be found in Appendix 5 to the request for quotation.
Section NName: Paramagnetic extracellular linear contrast media for MRI with renal excretion and partial biliary excretion.
Application: Intravenous. More possible.
Areas of application: MRI of the liver.
NSF risk: Medium NSF risk class.
Active ingredients / combinations (ATC): gadobenic acid (V08CA08).
Dosage forms: All approved dosage forms of an active ingredient.
Concentration: All concentrations possible.
Pack size: All approved pack sizes of the active ingredient.
Further information can be found in Appendix 5 to the request for quotation.
Section ODesignation: Paramagnetic combines extracellular and hepatobiliary linear contrast agents for MRI (excretion 50-50).
Application: Intravenous use. More possible.
Areas of application: MRI of the liver.
NSF risk: Medium NSF risk class.
Active ingredients / combinations (ATC): Gadoxetic acid (V08CA10).
Dosage forms: All dosage forms of the active ingredient.
Concentration: All concentrations possible.
Pack size: All pack sizes of the active ingredient.
Further information can be found in Appendix 5 to the request for quotation.
Section PDescription: Contrast media containing barium sulphate.
Application: Oral and / or intestinal and / or rectal use.
Areas of application: Representation of parts of the digestive tract and / or the entire digestive tract by CT and / or X-ray, others are possible.
Active ingredients / combinations (ATC): Barium sulfate (V08BA).
Dosage forms: All dosage forms of the active ingredient.
Concentration: All concentrations possible.
Pack size: All pack sizes of the active ingredient.
Further information can be found in Appendix 5 to the request for quotation.
Section QName: ultrasound contrast medium
Application: Intravenous use
Areas of application: echocardiography, others possible
Active ingredients / combinations (ATC): Phospholipid microspheres, containing perflutren (V08DA04)
Dosage form: all dosage forms of the active ingredient
Concentration: all concentrations possible
Pack size: all pack sizes of the active ingredient
Further information can be found in Appendix 5 to the request for quotation.